CONTEXT: The CACNA1C gene (alpha-1C subunit of the L-type voltage-gated calcium channel) has been identified as a risk gene for bipolar disorder and schizophrenia, but the mechanism of association has not been explored. OBJECTIVE: To identify the neural system mechanism that explains the genetic association between the CACNA1C gene and psychiatric illness using neuroimaging and human brain expression. DESIGN: We used blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) to measure brain activation in circuitries related to bipolar disorder and schizophrenia by comparing CACNA1C genotype groups among healthy subjects. We tested the effect of genotype on messenger RNA (mRNA) levels of CACNA1C in postmortem human brain. A case-control analysis was used to determine the association of CACNA1C genotype with schizophrenia. SETTING: National Institutes of Health Clinical Center. PATIENTS: Healthy men and women of white race/ethnicity participated in the fMRI study. Postmortem samples from normal human brains were used for the brain expression study. Patients with schizophrenia and healthy subjects were used in the case-control analysis. MAIN OUTCOME MEASURES: BOLD fMRI, mRNA levels in postmortem brain samples, and genetic association with schizophrenia. RESULTS: The risk-associated single-nucleotide polymorphism (SNP rs1006737) in CACNA1C predicted increased hippocampal activity during emotional processing (P = .001 uncorrected, P((false recovery rate [FDR])) = .05, z = 3.20) and increased prefrontal activity during executive cognition (P = 2.8e-05 uncorrected, P(FDR) = .01, z = 4.03). The risk-associated SNP also predicted increased expression of CACNA1C mRNA in human brain (P = .002). CACNA1C was associated with schizophrenia in our case-control sample (odds ratio, 1.77; P = .03). CONCLUSIONS: The risk-associated SNP in CACNA1C maps to circuitries implicated in genetic risk for bipolar disorder and schizophrenia. Its effects in human brain expression implicate a molecular and neural system mechanism for the clinical genetic association.
CONTEXT: The CACNA1C gene (alpha-1C subunit of the L-type voltage-gated calcium channel) has been identified as a risk gene for bipolar disorder and schizophrenia, but the mechanism of association has not been explored. OBJECTIVE: To identify the neural system mechanism that explains the genetic association between the CACNA1C gene and psychiatric illness using neuroimaging and human brain expression. DESIGN: We used blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) to measure brain activation in circuitries related to bipolar disorder and schizophrenia by comparing CACNA1C genotype groups among healthy subjects. We tested the effect of genotype on messenger RNA (mRNA) levels of CACNA1C in postmortem human brain. A case-control analysis was used to determine the association of CACNA1C genotype with schizophrenia. SETTING: National Institutes of Health Clinical Center. PATIENTS: Healthy men and women of white race/ethnicity participated in the fMRI study. Postmortem samples from normal human brains were used for the brain expression study. Patients with schizophrenia and healthy subjects were used in the case-control analysis. MAIN OUTCOME MEASURES: BOLD fMRI, mRNA levels in postmortem brain samples, and genetic association with schizophrenia. RESULTS: The risk-associated single-nucleotide polymorphism (SNP rs1006737) in CACNA1C predicted increased hippocampal activity during emotional processing (P = .001 uncorrected, P((false recovery rate [FDR])) = .05, z = 3.20) and increased prefrontal activity during executive cognition (P = 2.8e-05 uncorrected, P(FDR) = .01, z = 4.03). The risk-associated SNP also predicted increased expression of CACNA1C mRNA in human brain (P = .002). CACNA1C was associated with schizophrenia in our case-control sample (odds ratio, 1.77; P = .03). CONCLUSIONS: The risk-associated SNP in CACNA1C maps to circuitries implicated in genetic risk for bipolar disorder and schizophrenia. Its effects in human brain expression implicate a molecular and neural system mechanism for the clinical genetic association.
Authors: Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker Journal: Bioinformatics Date: 2008-10-30 Impact factor: 6.937
Authors: M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger Journal: Proc Natl Acad Sci U S A Date: 2001-05-29 Impact factor: 11.205
Authors: Ahmad R Hariri; Emily M Drabant; Karen E Munoz; Bhaskar S Kolachana; Venkata S Mattay; Michael F Egan; Daniel R Weinberger Journal: Arch Gen Psychiatry Date: 2005-02
Authors: Roberta Rasetti; Venkata S Mattay; Lisa M Wiedholz; Bhaskar S Kolachana; Ahmad R Hariri; Joseph H Callicott; Andreas Meyer-Lindenberg; Daniel R Weinberger Journal: Am J Psychiatry Date: 2008-12-15 Impact factor: 18.112
Authors: Vishnu P Murty; Fabio Sambataro; Saumitra Das; Hao-Yang Tan; Joseph H Callicott; Terry E Goldberg; Andreas Meyer-Lindenberg; Daniel R Weinberger; Venkata S Mattay Journal: J Cogn Neurosci Date: 2009-10 Impact factor: 3.225
Authors: Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger Journal: Science Date: 2002-07-19 Impact factor: 47.728
Authors: Heather C Whalley; James McKirdy; Liana Romaniuk; Jessika Sussmann; Eve C Johnstone; Hong I Wan; Andrew M McIntosh; Stephen M Lawrie; Jeremy Hall Journal: Bipolar Disord Date: 2009-12 Impact factor: 6.744
Authors: Barbara K Lipska; Tricia Peters; Thomas M Hyde; Nader Halim; Cara Horowitz; Shruti Mitkus; Cynthia Shannon Weickert; Mitsuyuki Matsumoto; Akira Sawa; Richard E Straub; Radhakrishna Vakkalanka; Mary M Herman; Daniel R Weinberger; Joel E Kleinman Journal: Hum Mol Genet Date: 2006-03-01 Impact factor: 6.150
Authors: Jennifer A Sumner; Margaret A Sheridan; Stacy S Drury; Kyle C Esteves; Kate Walsh; Karestan C Koenen; Katie A McLaughlin Journal: J Child Adolesc Psychopharmacol Date: 2015-09-24 Impact factor: 2.576
Authors: Amit Anand; Daniel L Koller; William B Lawson; Elliot S Gershon; John I Nurnberger Journal: J Affect Disord Date: 2015-03-10 Impact factor: 4.839
Authors: Axel Krug; Stephanie H Witt; Heidelore Backes; Bruno Dietsche; Vanessa Nieratschker; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher Journal: Eur Arch Psychiatry Clin Neurosci Date: 2013-07-17 Impact factor: 5.270
Authors: Peter S Jensen; Mark A Frye; Joanna M Biernacka; Paul E Croarkin; Joan L Luby; Kelly Cercy; Jennifer R Geske; Marin Veldic; Matthew Simonson; Paramjit T Joshi; Karen Dineen Wagner; John T Walkup; Malik M Nassan; Alfredo B Cuellar-Barboza; Leah Casuto; Susan L McElroy Journal: J Clin Psychiatry Date: 2017 Nov/Dec Impact factor: 4.384
Authors: Chenyang Tao; Thomas E Nichols; Xue Hua; Christopher R K Ching; Edmund T Rolls; Paul M Thompson; Jianfeng Feng Journal: Neuroimage Date: 2016-09-22 Impact factor: 6.556
Authors: John H Krystal; Alan Anticevic; Genevieve J Yang; George Dragoi; Naomi R Driesen; Xiao-Jing Wang; John D Murray Journal: Biol Psychiatry Date: 2017-01-13 Impact factor: 13.382
Authors: T M Reinbothe; S Alkayyali; E Ahlqvist; T Tuomi; B Isomaa; V Lyssenko; E Renström Journal: Diabetologia Date: 2012-11-15 Impact factor: 10.122